<DOC>
	<DOCNO>NCT00259623</DOCNO>
	<brief_summary>The objective study evaluate efficacy epicardial endocardial radiofrequency ablation treatment atrial fibrillation . It multicentric , prospective , randomize , parallel , comparative , double blind study . The study principal objective evaluate absence atrial fibrillation 3 month . The secondary objective consist evaluation maintenance sinusal heart rate one year quality life improvement</brief_summary>
	<brief_title>Cardiac Surgical Treatment Radiofrequency Ablation Valvular Patients : Efficacy 3 Months</brief_title>
	<detailed_description>Principal objective : To evaluate efficacy 3 month combine ablation technique treatment chronic atrial fibrillation cardiac surgery order obtain sinusal heart rate . A sequential statistical analysis result perform every 10 patient . In case validation principal objective sequential method i.e . prove superiority treatment ablation , , study would open pursue use ablation technique subsequent patient order validate secondary study objective Secondary objective : - To evaluate quality life patient one year absence atrial fibrillation relapse . - 6 12 month clinical follow-up - To evaluate left atrial function 6 month trans-oesophagus echocardiography</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Adult patient age limit , present chronic atrial fibrillation plan undergo surgical intervention mitral valve ( valve replacement plasty ) associate myocardial revascularization replacement/plasty another valve ( aortic , tricuspid ) The chronic atrial fibrillation define continuous atrial fibrillation 1 month surgery despite antiarrhythmia treatment include cardioversion ; atrial fibrillation associate another rhythm trouble except severe ventricular rhythm trouble . The indication surgery perform use clinical evaluation : NYHA &gt; 2 usual echocardiography criterion ( mitral regurgitation &gt; grade 3 , mitral gradient &gt; 10 mm Hg valve surface &lt; 1,5 cm2 ) Patients vital prognosis compromise comorbidity next 2 year mental state enable give inform consent Patients agree take part study sign informed consent form . For part study pursue open independent actual protocol , patient sign modify informed consent approval new study procedure yet publish . Paroxystic atrial fibrillation atrial fibrillation less 1 month Atrial fibrillation never treat cardioversion pharmacology surgery . Contraindication surgery , i.e . severe respiratory failure , multivisceral deficiency ( renal , cardiac hepatic ) , rapidly evolutive metastatic cancer , malignant hemopathies stabilize chemotherapy Contraindication follow arrhythmia treatment : class III ( amiodarone ) associate contraindication class II ( beta blocker ) class Ic ( flecainide , propafenone , cibenzoline ) . Severe decompensated heart failure . Uncontrolled , repetitive , severe document ventricular arrhythmia ( ventricular tachycardia , ventricular fibrillation episode ) Contra indication epicardic ablation procedure ( pericardic adhesion , intraatrial thrombus ) In case ablation could endocardic ablation necessarily exclude patient . Ventricular `` ejection fraction `` &lt; 40 % Impossibility follow preinclusion phase i.e . emergency surgery mitral break evolutive endocarditis . Patients disable mental status Patient participate another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>Radiofrequency ablation</keyword>
	<keyword>Atrial fibrillation</keyword>
</DOC>